Attorneys and Clients Behaving Badly Deliberately Withheld Offer for Sale Is Inequitable Conduct
Contributed by Knobbe Martens. Originally published on Patexia; republished here as part of the LexDana archive.
GS CLEANTECH CORP. v. ADKINS ENERGY LLC
Before, Reyna, Wallach, and Hughes. Appeal from the District Court for the Northern District of Illinois.
Summary: Withholding and obscuring evidence of a pre-critical date offer for sale renders a patent unenforceable for inequitable conduct.
On August 1, 2003, CleanTech sent Agri-Energy a proposal offering an ethanol processing system for a 60-day trial (the “Proposal”). At the end of the trial, Agri-Energy could either purchase or return the system. Without disclosing the Proposal to its patent counsel, on August 17, 2004 CleanTech filed its patent application for the processing system. In subsequent patent applications, CleanTech declared that its representatives hand-delivered the Proposal to Agri-Energy on August 18, 2003. CleanTech’s counsel did not question its client’s Declarations, despite having a copy of the Proposal email to Agri-Energy dated August 1, 2003. The USPTO ultimately issued CleanTech several patents covering its ethanol processing system.
In subsequent infringement litigation, the district court determined that the Proposal was a commercial offer for sale and evidence showed that the system was ready for patenting in August 2003. The Federal Circuit held this determination was not an abuse of discretion. The Federal Circuit also affirmed the ruling that both CleanTech and its counsel engaged in inequitable conduct. The Federal Circuit emphasized that CleanTech was aware of the statutory on-sale bar when it withheld the Proposal from the USPTO. CleanTech also made false Declarations to the USPTO by stating that the Proposal was delivered to Agri-Energy on August 18, 2003, when documents showed it was actually delivered on August 1, 2003. The court ruled that CleanTech’s counsel also engaged in inequitable conduct for failing to verify and correct CleanTech’s false Declaration.
Editor: Paul Stewart
Written by: Brok S. Humbert & Mark Kachner
More insights
Federal Circuit Affirms Invalidation of Patent for Lack of Enablement of Claims Directed to a Method of Treating a Patient with a Unit Dosage in Wyeth Llc v Astrazeneca Pharmaceuticals Lp
Written by : Eric Furman, Ph.D. and Ashley C. Morales Key Takeaway: Federal Circuit invalidates patent claims directed to a method for treating non-small cell lung cancer through administration of “a unit dosage” of an irreversible epidermal…
When About Becomes Indefinite Federal Circuit Provides Guidance for Life Science Patent Applications Regarding Limits of Approximation in Enviro Tech v Safe Foods
Written by : Jason J. Jardine and Kenneth O. Aruda, Ph.D. Key Takeaway: The term “about” remains useful in biotech and pharmaceutical claims, but only if the patent provides objective guidance about what the term means. Absent that guidance,…
When Any Patent Means No Patent Federal Circuit Reverses Non Specific Verdict
Written by : Brian C. Barnes and Sophia F. Zahn OLLNOVA TECHNOLOGIES LTD. v. ECOBEE TECHNOLOGIES ULC [OPINION] Before Chen , Cunningham, and Stark. Appeal from the United States District Court for the Eastern District of Texas. Summary : A verdict form…